News from NIAID-Supported Institutions
National Institute of Allergy and Infectious Diseases sent this bulletin at 11/29/2012 05:10 PM EST Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:Man’s Best Friend: Common Canine Virus May Lead to New Vaccines for Deadly Human Diseases
November 27, 2012—University of Georgia
Measles Vaccine Administered with a Microneedle Patch Could Enhance International Immunization Programs
November 27, 2012—Georgia Institute of Technology
Scripps Research Institute Study Points to Potential New Therapies for Cancer and Other Diseases
November 27, 2012—The Scripps Research Institute
GW Professor to Examine Infections in HIV Patients with Federal Grant
November 26, 2012—George Washington University School of Medicine and Health Sciences
‘Repurposed’ Anti-Parasite Drug Shows Promise as New TB Treatment: UBC Research
November 22, 2012—University of British Columbia
Scripps Research Institute Scientists Describe Elusive Replication Machinery of Flu Viruses
November 22, 2012—Scripps Research Institute
Texas Biomed Files Patent for a Novel HIV Vaccine Strategy
November 19, 2012—Texas Biomedical Research Institute
$19.4 Million Contract Establishes Malaria Research Consortium
November 19, 2012—Emory University
SSGCID and CSGID Pioneer Discovery of New Pathogen Protein Structures
November 19, 2012—Seattle BioMed
Hepatitis C Treatment's Side Effects Can Now Be Studied in the Lab
November 16, 2012—Penn State
Location, Location, Location: Membrane 'Residence' Gives Proteases Novel Abilities
November 16, 2012—Johns Hopkins Medicine
How Insects Domesticate Bacteria
November 15, 2012—University of Utah
News from NIAID-Supported Institutions
No hay comentarios:
Publicar un comentario